Scholar Rock Holding (SRRK) Non-Current Deffered Revenue (2017 - 2020)

Scholar Rock Holding (SRRK) recorded quarterly Non-Current Deffered Revenue of $33.2 million in Q4 2020, down 14.32% quarter-over-quarter from $38.7 million in Q3 2020, and down 28.6% on a YoY basis from $46.5 million in Q1 2020.

Scholar Rock Holding (SRRK) Non-Current Deffered Revenue (2017 - 2020) Analysis & Trends

Scholar Rock Holding's Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $33.2 million for Q4 2020.

  • In Q4 2020, Non-Current Deffered Revenue fell 28.6% year-over-year to $33.2 million; the TTM figure through Dec 2020 stood at $33.2 million (down 28.6% YoY), while the FY2020 annual figure was $33.2 million, down 28.6% from the prior year.
  • Non-Current Deffered Revenue was $33.2 million for Q4 2020 at Scholar Rock Holding, down from $38.7 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $46.5 million in Q4 2019 to a low of $468000.0 in Q4 2017.
  • Historically, Non-Current Deffered Revenue has averaged $28.6 million across 4 years, with a median of $33.8 million in 2019.
  • The sharpest annual moves came in 2018 and 2020: Non-Current Deffered Revenue jumped 9022.86% in 2018, then retreated 28.6% in 2020.
  • A 4-year view of Non-Current Deffered Revenue shows it stood at $468000.0 in 2017, then surged by 9022.86% to $42.7 million in 2018, then gained by 8.89% to $46.5 million in 2019, then declined by 28.6% to $33.2 million in 2020.
  • The last three Non-Current Deffered Revenue figures came in at $33.2 million (Q4 2020), $38.7 million (Q3 2020), and $38.1 million (Q2 2020), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 33.19 Mn
Sep 30, 2020 38.74 Mn
Jun 30, 2020 38.12 Mn
Mar 31, 2020 46.11 Mn
Dec 31, 2019 46.49 Mn
Sep 30, 2019 29.73 Mn
Jun 30, 2019 31.24 Mn
Mar 31, 2019 34.43 Mn
Dec 31, 2018 42.70 Mn
Sep 30, 2018 886,000.00
Jun 30, 2018 681,000.00
Dec 31, 2017 468,000.00